Antitumor Activity of 6-(cyclohexylamino)‎-1,3-dimethyl-5(2-pyridyl)‎furo[2,3-d]pyrimidine-2,4(1H,3H)‎-dione and Its Ti(IV)‎, Zn(II)‎, Fe(III)‎, and Pd(II)‎ Complexes on K562 and Jurkat Cell Lines

Abstract EN

(6-(cyclohexylamino)-1,3-dimethyl-5(2-pyridyl)furo[2,3-d]pyrimidine-2,4(1H,3H)-dione) abbreviated as CDP was synthesized and characterized.

Ti(IV), Zn(II), Fe(III), and Pd(II) metal complexes of this ligand are prepared by the reaction of salts of Ti(IV), Zn(II), Fe(III), and Pd(II) with CDP in acetonitrile.

Characterization of the ligand and its complexes was made by microanalyses, FT-IR, 1H NMR, 13C NMR, and UV-Visible spectroscopy.

All complexes were characterized by several techniques using elemental analysis (C, H, N), FT-IR, electronic spectra, and molar conductance measurements.

The elemental analysis data suggest the stoichiometry to be 1:1 [M:L] ratio formation.

The molar conductance measurements reveal the presence of 1:1 electrolytic nature complexes.

These new complexes showed excellent antitumor activity against two kinds of cancer cells that are K562 (human chronic myeloid leukemia) cells and Jurkat (human T lymphocyte carcinoma) cells.